Artykuły w czasopismach na temat „Early immune surveillance”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Early immune surveillance”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Schaller, Julien, i Judith Agudo. "Metastatic Colonization: Escaping Immune Surveillance". Cancers 12, nr 11 (16.11.2020): 3385. http://dx.doi.org/10.3390/cancers12113385.
Pełny tekst źródłaK, Geetha, i Lisa Anna Louis. "A Rare Case of Chorioangioma / Non Immune Fetal Hydrops". Indian Journal of Obstetrics and Gynecology 11, nr 3 (15.09.2023): 31–34. http://dx.doi.org/10.21088/ijog.2321.1636.11323.4.
Pełny tekst źródłaMitra, Roshni, Sarvjeet Singh i Ashok Khar. "Antitumour immune responses". Expert Reviews in Molecular Medicine 5, nr 3 (13.01.2003): 1–22. http://dx.doi.org/10.1017/s1462399403005623.
Pełny tekst źródłaFRIEDMANN, P. S., I. STRICKLAND, A. A. MEMON i P. M. JOHNSON. "Early time course of recruitment of immune surveillance in human skin after chemical provocation". Clinical & Experimental Immunology 91, nr 3 (28.06.2008): 351–56. http://dx.doi.org/10.1111/j.1365-2249.1993.tb05908.x.
Pełny tekst źródłaSopper, Sieghart, Satu Mustjoki, Angelica Loskog, Bjorn T. Gjertsen, Richard Greil, Alois Lang, Werner Linkesch i in. "Immune Monitoring In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib". Blood 122, nr 21 (15.11.2013): 2731. http://dx.doi.org/10.1182/blood.v122.21.2731.2731.
Pełny tekst źródłaBrandlmaier, Matthias, Magdalena Hoellwerth, Peter Koelblinger, Roland Lang i Andrea Harrer. "Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation". Cancers 16, nr 8 (11.04.2024): 1461. http://dx.doi.org/10.3390/cancers16081461.
Pełny tekst źródłaUrie, Russell R., Chengchuan Xiao, Elizabeth Hughes, Elizabeth Lombard, Judy Chen, Aaron Morris, Diana Farris, Daniel Goldstein i Lonnie Shea. "Tissue Engineering Scaffolds Remotely Surveil Presymptomatic Allograft Rejection". Journal of Immunology 210, nr 1_Supplement (1.05.2023): 173.40. http://dx.doi.org/10.4049/jimmunol.210.supp.173.40.
Pełny tekst źródłaBayó, Cristina, Gerhard Jung, Marta Español-Rego, Francesc Balaguer i Daniel Benitez-Ribas. "Vaccines for Non-Viral Cancer Prevention". International Journal of Molecular Sciences 22, nr 20 (9.10.2021): 10900. http://dx.doi.org/10.3390/ijms222010900.
Pełny tekst źródłaMorgado, Manuel, Ana Plácido, Sandra Morgado i Fátima Roque. "Management of the Adverse Effects of Immune Checkpoint Inhibitors". Vaccines 8, nr 4 (1.10.2020): 575. http://dx.doi.org/10.3390/vaccines8040575.
Pełny tekst źródłaHamatake, Kiyonori, i Kazuaki Kojima. "Initiatives for immune-related adverse events by the outpatient pharmacist clinic". Trends in Immunotherapy 6, nr 1 (10.01.2022): 3. http://dx.doi.org/10.24294/ti.v6.i1.1385.
Pełny tekst źródłaWang, Xinlu, Melody M. H. Li, Jing Zhao, Shenglan Li, Margaret R. MacDonald, Charles M. Rice, Xiang Gao i Guangxia Gao. "Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance". Journal of Virology 90, nr 22 (31.08.2016): 10247–58. http://dx.doi.org/10.1128/jvi.01487-16.
Pełny tekst źródłaPeng, Ling, Yongchang Zhang i Zibing Wang. "Immune Responses against Disseminated Tumor Cells". Cancers 13, nr 11 (21.05.2021): 2515. http://dx.doi.org/10.3390/cancers13112515.
Pełny tekst źródłaLiu, Ping, Yan Hong, Bincai Yang, Prasha Shrestha, Nelam Sajjad i Ji-Long Chen. "Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses". Viruses 12, nr 9 (18.09.2020): 1039. http://dx.doi.org/10.3390/v12091039.
Pełny tekst źródłavan Dommelen, Serani L. H., Hyacinth A. Tabarias, Mark J. Smyth i Mariapia A. Degli-Esposti. "Activation of Natural Killer (NK) T Cells during Murine Cytomegalovirus Infection Enhances the Antiviral Response Mediated by NK Cells". Journal of Virology 77, nr 3 (1.02.2003): 1877–84. http://dx.doi.org/10.1128/jvi.77.3.1877-1884.2003.
Pełny tekst źródłaGasser, M., M. Grimm, E. Nichiporuk, M. Bueter, J. Lutz, T. Lebedeva, M. Koenigshausen i in. "PD-1/PDL-1 expression in colorectal cancer and its implications for tumor immune evasion". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 10046. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10046.
Pełny tekst źródłaAtif, Shaikh M., Sophie L. Gibbings, Elizabeth F. Redente, Faye A. Camp, Raul M. Torres, Ross M. Kedl, Peter M. Henson i Claudia V. Jakubzick. "Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity". American Journal of Respiratory Cell and Molecular Biology 59, nr 5 (listopad 2018): 580–91. http://dx.doi.org/10.1165/rcmb.2018-0159oc.
Pełny tekst źródłaProescholdt, Martin A., Marsha J. Merrill, Barbara Ikejiri, Stuart Walbridge, Aytac Akbasak, Steven Jacobson i Edward H. Oldfield. "Site-specific immune response to implanted gliomas". Journal of Neurosurgery 95, nr 6 (grudzień 2001): 1012–19. http://dx.doi.org/10.3171/jns.2001.95.6.1012.
Pełny tekst źródłaHoulahan, Kathleen, Aziz Khan i Christina Curtis. "Abstract 5954: Germline epitopes modulate immune surveillance informing breast cancer subtypes". Cancer Research 83, nr 7_Supplement (4.04.2023): 5954. http://dx.doi.org/10.1158/1538-7445.am2023-5954.
Pełny tekst źródłaNikiforow, Sarah, Kim Bottomly i George Miller. "CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation". Journal of Virology 75, nr 8 (15.04.2001): 3740–52. http://dx.doi.org/10.1128/jvi.75.8.3740-3752.2001.
Pełny tekst źródłaSingh, K. K. "Expression of PD-L1 in human placenta and retained product of conception of early pregnancy loss". American Journal of Clinical Pathology 160, Supplement_1 (1.11.2023): S80. http://dx.doi.org/10.1093/ajcp/aqad150.178.
Pełny tekst źródłaGao, Zetian, Qiubo Zhang, Xie Zhang i Yufei Song. "Advance of T regulatory cells in tumor microenvironment remodeling and immunotherapy in pancreatic cancer". European Journal of Inflammation 20 (styczeń 2022): 1721727X2210929. http://dx.doi.org/10.1177/1721727x221092900.
Pełny tekst źródłaChristakou, Athanasia E., Mathias Ohlin, Björn Önfelt i Martin Wiklund. "Ultrasonic three-dimensional on-chip cell culture for dynamic studies of tumor immune surveillance by natural killer cells". Lab on a Chip 15, nr 15 (2015): 3222–31. http://dx.doi.org/10.1039/c5lc00436e.
Pełny tekst źródłaMestrallet, Guillaume. "Abstract 6652: Overcoming immune resistance in DNA mismatch repair deficient tumors". Cancer Research 83, nr 7_Supplement (4.04.2023): 6652. http://dx.doi.org/10.1158/1538-7445.am2023-6652.
Pełny tekst źródłaCedro-Tanda, Alberto, Laura Gómez-Romero, Guillermo de Anda-Jauregui, Dora Garnica-López, Yair Alfaro-Mora, Sonia Sánchez-Xochipa, Eulices F. García-García i in. "Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City". Viruses 14, nr 3 (6.03.2022): 545. http://dx.doi.org/10.3390/v14030545.
Pełny tekst źródłaRadom-Aizik, Shlomit. "Immune Response to Exercise During Growth". Pediatric Exercise Science 29, nr 1 (luty 2017): 49–52. http://dx.doi.org/10.1123/pes.2017-0003.
Pełny tekst źródłaSu, Alan, Rodrigo Pedraza i Hagen Kennecke. "Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer". Current Oncology 30, nr 4 (26.03.2023): 3672–83. http://dx.doi.org/10.3390/curroncol30040279.
Pełny tekst źródłaVenkatesh, Vishnu, Christine Yen, Ray Zhang, Anjali Rao, Alvin Chandra, Vlad Zaha, Srilakshmi Vallabhaneni i Kathleen W. Zhang. "Prospective cardiovascular surveillance of immune checkpoint inhibitor-based combination therapy in patients with early-stage, triple-negative breast cancer." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 2607. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.2607.
Pełny tekst źródłaXu, Wenxi, Laura M. Snell, Mengdi Guo, Giselle Boukhaled, Bethany L. Macleod, Ming Li, Michael V. Tullius i in. "Uncovering the underlying immune perturbations that determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection". Journal of Immunology 206, nr 1_Supplement (1.05.2021): 62.08. http://dx.doi.org/10.4049/jimmunol.206.supp.62.08.
Pełny tekst źródłaMcWilliam, Andrew S., Sylvia Napoli, Amanda M. Marsh, Francis L. Pemper, Delia J. Nelson, Carolyn L. Pimm, Philip A. Stumbles, Timothy N. C. Wells i Patrick G. Holt. "Dendritic Cells Are Recruited into the Airway Epithelium during the Inflammatory Response to a Broad Spectrum of Stimuli". Journal of Experimental Medicine 184, nr 6 (1.12.1996): 2429–32. http://dx.doi.org/10.1084/jem.184.6.2429.
Pełny tekst źródłaVan Neste, Leander, Kirk J. Wojno, Ricardo Henao, Shrikant Mane, Howard Korman, Jason Hafron, Kenneth Kernen i in. "Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer". Cells 10, nr 10 (28.09.2021): 2567. http://dx.doi.org/10.3390/cells10102567.
Pełny tekst źródłaCui, Min, Jiaolong Yuan, Chong Wang, Nan Zhang, Ke Wang, Kunlun Wang, Pingdong Hu, Xianwu Lin, Hong Yang i Zhenfang Fu. "Inhibition of T cell response by Japanese encephalitis virus: a mechanism of immune evasion (VIR5P.1019)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 144.2. http://dx.doi.org/10.4049/jimmunol.192.supp.144.2.
Pełny tekst źródłaPankowska, Katarzyna Aneta, Grażyna Ewa Będkowska, Joanna Chociej-Stypułkowska, Małgorzata Rusak, Milena Dąbrowska i Joanna Osada. "Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance". International Journal of Molecular Sciences 24, nr 11 (25.05.2023): 9279. http://dx.doi.org/10.3390/ijms24119279.
Pełny tekst źródłaKim, Hyoji, Hoyun Choi i Suk Kyeong Lee. "Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by InhibitingBAD-Mediatedcaspase-3-Dependent Apoptosis". Journal of Virology 90, nr 3 (18.11.2015): 1359–68. http://dx.doi.org/10.1128/jvi.02794-15.
Pełny tekst źródłaEaton, Valerie L., Damiano Fantini, Yanni Yu, Ming-Yi Chiang, Joshua Meeks, Joseph R. Podojil i Stephen D. Miller. "Early Suppression of Immune Regulatory Mechanisms Reduces Tumor Progression in a Murine Model of Urothelial Cancer". Journal of Immunology 204, nr 1_Supplement (1.05.2020): 244.9. http://dx.doi.org/10.4049/jimmunol.204.supp.244.9.
Pełny tekst źródłaRao, Chinthalapally V., Chao Xu, Mudassir Farooqui, Yuting Zhang, Adam S. Asch i Hiroshi Y. Yamada. "Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma". Cancers 13, nr 11 (25.05.2021): 2586. http://dx.doi.org/10.3390/cancers13112586.
Pełny tekst źródłaKline, Justin, James Godfrey i Stephen M. Ansell. "The immune landscape and response to immune checkpoint blockade therapy in lymphoma". Blood 135, nr 8 (20.02.2020): 523–33. http://dx.doi.org/10.1182/blood.2019000847.
Pełny tekst źródłaKosova, A. A., V. I. Chalapa, T. M. Itani i A. V. Semenov. "Epidemiological portrait of noroviral infection". Ural Medical Journal 21, nr 3 (7.07.2022): 114–28. http://dx.doi.org/10.52420/2071-5943-2022-21-3-114-128.
Pełny tekst źródłaFeng, Haokang, Jiale Feng, Xu Han, Ying Ying, Wenhui Lou, Liang Liu i Lei Zhang. "The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy". Cancers 16, nr 2 (10.01.2024): 289. http://dx.doi.org/10.3390/cancers16020289.
Pełny tekst źródłaSow, Mamadou Saliou, Josue Togo, Lacy M. Simons, Souleymane Taran Diallo, Mohamed Lamine Magassouba, Mamadou Bhoye Keita, Anou Moise Somboro i in. "Genomic characterization of SARS-CoV-2 in Guinea, West Africa". PLOS ONE 19, nr 3 (6.03.2024): e0299082. http://dx.doi.org/10.1371/journal.pone.0299082.
Pełny tekst źródłaXu, Yan, Yao Yao, Woojun Daniel Park, Sanika Derebail, Chandraditya Chakraborty, Shidai Mu, Rafael Alonso Fernández i in. "Enhancing the Immune Surveillance in Multiple Myeloma Via CDK4/6 Inhibition". Blood 136, Supplement 1 (5.11.2020): 33–34. http://dx.doi.org/10.1182/blood-2020-143327.
Pełny tekst źródłaLi, Xue, Kaifeng Pan, Michael Vieth, Markus Gerhard, Wenqing Li i Raquel Mejiías-Luque. "JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis". International Journal of Molecular Sciences 23, nr 8 (8.04.2022): 4147. http://dx.doi.org/10.3390/ijms23084147.
Pełny tekst źródłaAddissouky, Tamer A., Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Yuliang Wang, Ayman El Baz, Ahmed A. Khalil i Naglaa Elarabany. "Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions". Journal of Cellular Immunology 5, nr 4 (29.11.2023): 127–40. http://dx.doi.org/10.33696/immunology.5.178.
Pełny tekst źródłaRossi, Matilde, Nicole Cruz-Reyes, Melody L. Stallings Mann, Bryan M. McCauley, Tanya L. Hoskin, Robert A. Vierkant, Stacey J. Winham, Amy C. Degnim, Mark E. Sherman i Derek C. Radisky. "Abstract 4773: Interferon regulatory factor 8 (IRF8) as a biomarker for early detection and prevention of axillary lymph node-positive breast cancer". Cancer Research 84, nr 6_Supplement (22.03.2024): 4773. http://dx.doi.org/10.1158/1538-7445.am2024-4773.
Pełny tekst źródłaShimozaki, Keitaro, Kenro Hirata, Sara Horie, Akihiko Chida, Kai Tsugaru, Yukie Hayashi, Kenta Kawasaki i in. "The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study". Diagnostics 11, nr 3 (18.03.2021): 543. http://dx.doi.org/10.3390/diagnostics11030543.
Pełny tekst źródłaGan, Chai, Bernard Kok Bang Lee, Shin Hin Lau, Thomas George Kallarakkal, Zuraiza Mohamad Zaini, Rosnah Binti Zain, Hans Prakash Sathasivam i in. "911 Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (listopad 2021): A957. http://dx.doi.org/10.1136/jitc-2021-sitc2021.911.
Pełny tekst źródłaEngin, Ayse Basak, Riza Onder Gunaydin, Sacit Altug Kesikli, Dietmar Fuchs i Ali Sefik Hosal. "Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma". Pteridines 28, nr 2 (28.08.2017): 91–95. http://dx.doi.org/10.1515/pterid-2017-0004.
Pełny tekst źródłaLeo, Isabella, Mahesh Vidula, Giandomenico Bisaccia, Maria Cristina Procopio, Roberto Licordari, Maria Perotto, Giulia La Vecchia, Nikolaos Miaris, Paco E. Bravo i Chiara Bucciarelli-Ducci. "The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity". Journal of Clinical Medicine 12, nr 15 (27.07.2023): 4945. http://dx.doi.org/10.3390/jcm12154945.
Pełny tekst źródłaSantibanez, Juan F., i Suncica Bjelica. "Transforming Growth Factor-Beta1 and Myeloid-Derived Suppressor Cells Interplay in Cancer". Open Cancer Immunology Journal 6, nr 1 (12.10.2017): 1–14. http://dx.doi.org/10.2174/1876401001706010001.
Pełny tekst źródłaNí Chasaide, Caitlín, i Marina A. Lynch. "The role of the immune system in driving neuroinflammation". Brain and Neuroscience Advances 4 (styczeń 2020): 239821281990108. http://dx.doi.org/10.1177/2398212819901082.
Pełny tekst źródłaAntea, Krsek, Krpina Kristina, Samarzija Miroslav, Detel Dijana, Baticic Lara i Sotosek Vlatka. "Immunotherapy in cancer: Where we are and what the future brings?" Trends in Immunotherapy 7, nr 2 (12.10.2023): 2186. http://dx.doi.org/10.24294/ti.v7.i2.2186.
Pełny tekst źródła